Madrigal Pharmaceuticals (MDGL) News Today $425.48 -1.57 (-0.37%) As of 10:59 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MDGL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Madrigal Pharmaceuticals management to meet with B. RileySeptember 17 at 3:58 AM | msn.comIntech Investment Management LLC Purchases 1,696 Shares of Madrigal Pharmaceuticals, Inc. $MDGLSeptember 15 at 3:20 AM | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Average Rating of "Moderate Buy" by AnalystsSeptember 15 at 3:00 AM | marketbeat.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Given New $526.00 Price Target at Canaccord Genuity GroupSeptember 14 at 9:12 AM | marketbeat.comMadrigal Pharmaceuticals, Inc. $MDGL Shares Purchased by Rhumbline AdvisersSeptember 13, 2025 | marketbeat.comMarketBeat Week in Review – 09/08 - 09/12 (MDGL)Markets had another strong week as inflaton data set the stage for the Federal Reserve’s meeting next week; a rate cut is expected but may already be priced in...September 13, 2025 | marketbeat.comEP Wealth Advisors LLC Takes Position in Madrigal Pharmaceuticals, Inc. $MDGLSeptember 13, 2025 | marketbeat.comA Glimpse Into The Expert Outlook On Madrigal Pharmaceuticals Through 6 AnalystsSeptember 12, 2025 | benzinga.comWilliam John Sibold Sells 7,279 Shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) StockSeptember 11, 2025 | marketbeat.comWoodline Partners LP Buys 8,316 Shares of Madrigal Pharmaceuticals, Inc. $MDGLSeptember 11, 2025 | marketbeat.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Hits New 12-Month High - What's Next?September 10, 2025 | marketbeat.comCoreWeave and Madrigal's Insider Trades Flash Bullish Signals (MDGL)Insider trades at NVIDIA-backed CoreWeave and Madrigal Pharmaceuticals are bullish indicators, but for very different reasons.September 10, 2025 | marketbeat.comMadrigal Pharmaceuticals (NASDAQ:MDGL) CEO William John Sibold Sells 7,279 SharesSeptember 10, 2025 | insidertrades.comA Fresh Look at Madrigal Pharmaceuticals (MDGL) Valuation Following Recent Share Price MomentumSeptember 9, 2025 | finance.yahoo.comWhat is HC Wainwright's Forecast for MDGL Q3 Earnings?September 9, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (MDGL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 8, 2025 | seekingalpha.comCinctive Capital Management LP Reduces Position in Madrigal Pharmaceuticals, Inc. $MDGLSeptember 8, 2025 | marketbeat.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Receives Buy Rating from HC WainwrightSeptember 6, 2025 | marketbeat.comCutter Capital Management LP Purchases New Shares in Madrigal Pharmaceuticals, Inc. $MDGLSeptember 6, 2025 | marketbeat.comAllostery Investments LP Buys Shares of 600 Madrigal Pharmaceuticals, Inc. $MDGLSeptember 5, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Has $63.47 Million Holdings in Madrigal Pharmaceuticals, Inc. $MDGLSeptember 5, 2025 | marketbeat.comMadrigal Pharmaceuticals assumed with a Buy at H.C. WainwrightSeptember 4, 2025 | msn.comTD Cowen Sees Greater Upside in Madrigal (MDGL) Following Recent Rezdiffra ApprovalSeptember 4, 2025 | msn.comMadrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)September 4, 2025 | globenewswire.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Sets New 52-Week High - What's Next?September 4, 2025 | marketbeat.comADAR1 Capital Management LLC Invests $494,000 in Madrigal Pharmaceuticals, Inc. $MDGLSeptember 4, 2025 | marketbeat.comMPM Bioimpact LLC Makes New Investment in Madrigal Pharmaceuticals, Inc. $MDGLSeptember 4, 2025 | marketbeat.comQuarry LP Invests $232,000 in Madrigal Pharmaceuticals, Inc. $MDGLSeptember 4, 2025 | marketbeat.comMadrigal Pharmaceuticals to Participate in Morgan Stanley 23rd Annual Global Healthcare ConferenceSeptember 3, 2025 | globenewswire.comPaulson & CO. Inc. Grows Stake in Madrigal Pharmaceuticals, Inc. $MDGLSeptember 3, 2025 | marketbeat.com48,690 Shares in Madrigal Pharmaceuticals, Inc. $MDGL Purchased by Braidwell LPSeptember 3, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. $MDGL is Propel Bio Management LLC's 2nd Largest PositionSeptember 2, 2025 | marketbeat.comLandscape Capital Management L.L.C. Acquires 3,083 Shares of Madrigal Pharmaceuticals, Inc. $MDGLAugust 31, 2025 | marketbeat.comTema Etfs LLC Cuts Stock Position in Madrigal Pharmaceuticals, Inc. $MDGLAugust 30, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. $MDGL Shares Sold by Tri Locum Partners LPAugust 30, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. $MDGL Stake Lessened by Rafferty Asset Management LLCAugust 30, 2025 | marketbeat.comNorthern Trust Corp Decreases Stock Holdings in Madrigal Pharmaceuticals, Inc. $MDGLAugust 30, 2025 | marketbeat.comLeerink Partners Maintains a Buy on Madrigal Pharmaceuticals (MDGL), Here’s WhyAugust 29, 2025 | finance.yahoo.comAffinity Asset Advisors LLC Has $26.50 Million Stake in Madrigal Pharmaceuticals, Inc. $MDGLAugust 28, 2025 | marketbeat.comBiopharma and Energy Execs Lead Weekly Insider BuyingAugust 28, 2025 | 247wallst.comTD Cowen Forecasts Strong Price Appreciation for Madrigal Pharmaceuticals (NASDAQ:MDGL) StockAugust 28, 2025 | marketbeat.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Reaches New 52-Week High - Should You Buy?August 27, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. $MDGL Stock Position Decreased by Price T Rowe Associates Inc. MDAugust 27, 2025 | marketbeat.comMadrigal Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)August 26, 2025 | benzinga.comMadrigal Pharmaceuticals, Inc. $MDGL is University of Wisconsin Foundation's 3rd Largest PositionAugust 26, 2025 | marketbeat.comDo You Believe in the Upside Potential of Madrigal Pharmaceuticals (MDGL)?August 25, 2025 | insidermonkey.comCandriam S.C.A. Buys New Position in Madrigal Pharmaceuticals, Inc. $MDGLAugust 24, 2025 | marketbeat.comNuveen LLC Buys New Shares in Madrigal Pharmaceuticals, Inc. $MDGLAugust 23, 2025 | marketbeat.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Raised to $485.00 at JMP SecuritiesAugust 22, 2025 | marketbeat.comWilliam John Sibold Sells 7,616 Shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) StockAugust 22, 2025 | insidertrades.com Get Madrigal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MDGL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MDGL Media Mentions By Week MDGL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDGL News Sentiment▼0.990.92▲Average Medical News Sentiment MDGL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDGL Articles This Week▼1310▲MDGL Articles Average Week Get the Latest News and Ratings for MDGL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Madrigal Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Biogen News Today United Therapeutics News Today Incyte News Today Neurocrine Biosciences News Today Exelixis News Today BioMarin Pharmaceutical News Today Exact Sciences News Today Ionis Pharmaceuticals News Today Halozyme Therapeutics News Today Repligen News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDGL) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Madrigal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Madrigal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
